ArticleThe Journal of infection2020

Safety and efficacy of anti-il6-receptor tocilizumab use in severe and critical patients affected by coronavirus disease 2019: A comparative analysis.

Roberto Rossotti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.